Propanc Biopharma, Inc.
PPCBNasdaqCIK 1517681HealthcareFiscal year ends Jun 30
Reports and events: 233 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2021-09-2815:53 ET | 10-K | Annual reportPeriod 2021-06-30 | 0001493152-21-023973 |
| 2021-09-2809:01 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-023930 |
| 2021-08-2506:20 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-021170 |
| 2021-08-1806:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-21-020496 |
| 2021-05-1417:25 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001493152-21-011560 |
| 2021-03-1913:38 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-006397 |
| 2021-02-1215:12 ET | 10-Q | Quarterly reportPeriod 2020-12-31 | 0001493152-21-003609 |
| 2021-01-1111:40 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-21-000709 |
| 2020-12-3014:35 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001493152-20-024549 |
| 2020-12-1612:47 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-023733 |
| 2020-12-0709:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-023015 |
| 2020-11-1910:41 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001493152-20-022006 |
| 2020-11-1611:55 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001493152-20-021528 |
| 2020-11-0317:08 ET | S-1/A | Registration statement, amended | 0001493152-20-020409 |
| 2020-10-1421:57 ET | S-1/A | Registration statement, amended | 0001493152-20-019397 |
| 2020-10-0117:29 ET | 10-K | Annual reportPeriod 2020-06-30 | 0001493152-20-018726 |
| 2020-08-1308:12 ET | S-1/A | Registration statement, amended | 0001493152-20-015435 |
| 2020-07-1719:38 ET | S-1/A | Registration statement, amended | 0001493152-20-013482 |
| 2020-06-2617:30 ET | S-1/A | Registration statement, amended | 0001493152-20-011964 |
| 2020-05-1516:36 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001493152-20-009146 |
| 2020-05-1317:50 ET | S-1 | Registration statement | 0001493152-20-008544 |
| 2020-04-0317:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-005802 |
| 2020-02-1417:21 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0001493152-20-002576 |
| 2020-01-2417:11 ET | S-1/A | Registration statement, amended | 0001493152-20-001059 |
| 2020-01-1717:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-20-000761 |
| 2019-12-1217:48 ET | S-1 | Registration statement | 0001493152-19-019118 |
| 2019-11-1417:07 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001493152-19-017566 |
| 2019-10-1517:41 ET | 10-K | Annual reportPeriod 2019-06-30 | 0001493152-19-015529 |
| 2019-10-0817:15 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-015251 |
| 2019-09-0916:45 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-013872 |
| 2019-08-0616:53 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-011734 |
| 2019-07-1017:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-010470 |
| 2019-07-0117:58 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-19-009913 |
| 2019-06-2117:00 ET | 8-K | 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-009581 |
| 2019-06-1417:48 ET | S-1/A | Registration statement, amended | 0001493152-19-009248 |
| 2019-05-3017:04 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-008432 |
| 2019-05-2322:22 ET | S-1 | Registration statement | 0001493152-19-008117 |
| 2019-05-1516:51 ET | 10-Q | Quarterly reportPeriod 2019-03-31 | 0001493152-19-007459 |
| 2019-05-1516:10 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001493152-19-007395 |
| 2019-02-2517:44 ET | S-1 | Registration statement | 0001493152-19-002526 |
| 2019-02-2517:01 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-19-002513 |
| 2019-02-1416:07 ET | 10-Q | Quarterly reportPeriod 2018-12-31 | 0001493152-19-002072 |
| 2019-02-1209:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001493152-19-001741 |
| 2018-12-2816:30 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-018073 |
| 2018-12-0617:00 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-017138 |
| 2018-11-1318:30 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001493152-18-015599 |
| 2018-10-1717:34 ET | S-1 | Registration statement | 0001493152-18-014592 |
| 2018-10-1006:15 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-014307 |
| 2018-10-0516:46 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits | 0001493152-18-014184 |
| 2018-09-2706:04 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001493152-18-013790 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 17:01 ET. Listed shows no prices and gives no investment advice.